| |
Monday, 11th January 2010
|
Time |
Topic |
Speaker |
|
19:30 – 20:30 |
Opening Ceremony |
|
|
|
Moderator |
Meshal Almutairi, Pharm.D., BCPS |
|
20:30 – 21:00 |
Keynote Speaker |
James Tisdale, Pharm.D, BCPS, FCCP |
|
21:00 – 21:30 |
Discussion |
|
|
22:00 |
Dinner |
Tuesday, 12th January 2010
|
Time |
Topic |
Speaker |
|
07:00 – 08:00 |
Breakfast / Registration |
|
SESSION I |
|
Acute Coronary Syndrome (ACS) |
|
|
Moderator |
Meshal Almutairi, Pharm.D., BCPS |
|
08:00 – 08:25 |
Stepwise Evaluation and Management |
Paul Dobesh, Pharm.D., FCCP, BCPS |
|
08:25 – 08:50 |
Antithrombotic Therapy: A Practical and Evidence-Based Approach |
Paul Dobesh, Pharm.D., FCCP, BCPS |
|
08:50 – 09:15 |
Bleeding Complications: Prevention and Management |
Reginald Smith, Pharm.D., ACPR |
|
09:15 – 09:30 |
Discussion |
|
|
0930 – 10:00 |
Official Opening Ceremony |
|
|
SESSION II |
|
Percutaneous Coronary Intervention (PCI) |
|
|
Moderator |
Nathem Akhraus, Pharm.D., |
|
10:00 – 10:25 |
How to Strategy the Patient before PCI |
Abdz Jaziri, Pharm.D., BCPS, FCCP |
|
10:25 – 10:50 |
Post-PCI Antiplatelet Therapy: Optimal Dosage and Duration |
Robert Talbert, Pharm D, FCCP, BCPS |
|
10:50 – 11:15 |
Drug Eluting Stents: Assessing the Risks and Benefits |
Paul Dobesh, Pharm.D., FCCP, BCPS |
|
11:15 – 11:25 |
Discussion |
|
|
|
|
SESSION III |
|
Heart Failure (HF) |
|
|
Moderator |
Walid Shaqha, PhD. Pharm.D |
|
11:25– 11:50 |
Evaluation, Diagnosis and Treatment of CHF: The Optimal Drug Therapy |
James Tisdale, Pharm.D, BCPS, FCCP |
|
11:50 – 12:15 |
ADHF: Current and Novel Pharmacotherapeutic Approaches |
Antoine Joseph Cherfan, Pharm.D., BCPS, FCCP |
|
12:15 – 12:40 |
Impact of Anemia in Patients with Heart Failure |
Nada Alqadheib, Pharm.D., BCPS, FCCP |
|
12:40 – 12:50 |
Discussion |
|
12:50 – 14:00 |
Prayer Time, Lunch Break, Exhibition |
|
SESSION IV |
|
Dyslipidemia |
|
|
Moderator |
Ahmed Aljedaie, Pharm.D., BCPS, FCCP |
|
14:00 – 14:25 |
The Evidence Update and Prospect of Dyslipidemia Management in Cardiac Patient |
Nathem Akhraus, Pharm.D |
|
14:25 – 14:50 |
Newer Indications and Limitations of Statin Therapy |
Abdz Jaziri, Pharm.D., BCPS, FCCP |
|
14:50 – 15:15 |
HDL Raising Drugs: Failure or Success? |
Abdulaziz Tuwaijri, MS Pharm |
|
15:15-15:40 |
Medication safety of antihyperlipidemic agents |
Ghada Bawazeer, Pharm.D., BCPS |
|
15:40 – 16:00 |
Discussion |
|
End of 1st day |
Wednesday, 13th January 2010
|
Time |
Topic |
Speaker |
|
SESSION I |
|
07:00 – 08:00 |
Breakfast |
|
Arrhythmia |
|
|
Moderator |
Abdz Jaziri, Pharm.D., BCPS, FCCP |
|
08:00 – 08:25 |
Pharmacological Therapy for Atrial Fibrillation: A Practical approach and review of guidelines |
James Tisdale, Pharm.D, BCPS, FCCP |
|
08:25 – 08:50 |
Vascular Events Prevention in Atrial Fibrillation: Guidelines and Future Directions |
Nathem Akhraus, Pharm.D. |
|
08:50 – 09:15 |
Old and New Antiarrhythmic Medications: Current Directions |
Muneera Albabtain, MS Pharm |
|
09:15 – 09:30 |
Discussion |
|
09:30 – 09:40 |
Break |
|
SESSION II |
|
Venous Thromboembolism (VTE) |
|
|
Moderator |
Paul Dobesh, Pharm.D., FCCP, BCPS |
|
09:40 – 10:05 |
VTE: Diagnosis and Management |
Reginald Smith, Pharm. D., ACPR |
|
10:05 – 10:30 |
Novel Anti-Coagulants: The Future of Warfarin |
Reginald Smith, Pharm. D., ACPR |
|
10:30 – 10:55 |
Frontiers of Treatment on Valvular Heart Disease: Focus on Antithrombotic Therapy |
Iman Obari, MS Pharm, BCPS |
|
10:55 – 11:10 |
Discussion |
|
11:10 – 11:20 |
Break |
|
SESSION III |
|
Hypertension |
|
|
Moderator |
Iad Shaheen, Pharm.D |
|
11:20 – 11:45 |
Antihypertensive Therapy of Hypertensive Cardiovascular Disease |
Meshal Almutairi, Pharm.D., BCPS |
|
11:45 – 12:10 |
Review of Recently Published Clinical Trial s in Hypertension |
Robert Talbert, Pharm D, FCCP, BCPS |
|
12:10 – 12:35 |
ACEIs, ARBs or Combined? |
Ahmed Aljedaie, Pharm.D., BCPS, FCCP |
|
12:35 – 12:50 |
Discussion |
|
12:50 – 14:00 |
Prayer Time, Lunch Break, Exhibition |
|
SESSION IV |
|
Ambulatory Care Cardiology |
|
|
Moderator |
Robert Talbert, Pharm D, FCCP, BCPS |
|
14:00 – 14:25 |
Cardiac Rehabilitation: Measures and Tools |
Fadwa Alkhuraisi, Bsc.Pharm.SCSCP |
|
14:25 – 14:50 |
DM management and its cardiovascular implications |
Muneera Albabtain, MS Pharm |
|
14:50 – 15:15 |
Stable CAD: Newer Agents and Maximal Drug Therapy |
Paul Dobesh, Pharm.D., FCCP, BCPS |
|
15:15 – 15:40 |
Outcomes of Pharmacist Medication Management of Chronic CHF |
Michael Murray, PharmD, MPH |
|
15:40 – 16:00 |
Discussion |
|
|
16:00 – 16:30 |
Closing Ceremony |
Workshops:
| 1. Role of the Pharmacist in Improving the Management of Chronic CHF |
2. ECG: Applications for Pharmacists |
| Tuesday: 12th January 2010 |
Wednesday: 13th January 2010 |
| Time: 14:00 – 15:30 |
Time: 14:00 – 15:30 |
Part I: overview, Tools, Measures:
14:00-14:30
Michael Murray, PharmD, MPH
Break: 14:30-14:45 |
Part I: overview, Tools, Measures:
14:00-14:30
Ahmed Faqih, MD, Consultant Cardiologist
Break: 14:30-14:45 |
Part II: Practical Cases
14:45-15:30
Walid Shaqha, PhD. Pharm.D
Michael Murray, PharmD, MPH |
Part II: Practical Cases
14:45-15:30
Ahmed Faqih, MD, Consultant Cardiologist |
| |
|